ALNYLAM PHARMACEUTICALS INC
ALNYNASDAQ$252.76▼ $2.58 (−1.02%)
LiveTrack ALNY
Get earnings, price moves & breaking news on Telegram
24h▼ 1.0%
7d▲ 0.4%
14d▲ 6.1%
30d▲ 6.7%
ytd▼ 36.4%
1y▼ 43.5%
🏦Market Cap
$33.82B
Mid Cap
📈Revenue Growth (YoY)
+65.2%
High Growth
📊Gross Margin
79.7%
High
💵FCF Margin
11.3%
Healthy
⚖️P/S Ratio
7.1x
Fair
Otter Score
56
Weak
ALNYLAM PHARMACEUTICALS INC
ALNYAnalyst Ratings
Price
$252.76
Total
52
Raised
5
Lowered
2
Avg PT
$347.33
H / L
$455 / $256
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
HC Wainwright & Co. | Reiterated | Buy | 2026-09-21 | — | — |
Jefferies | Reiterated | Hold | 2026-09-08 | $260.00 | +2.90% |
BMO Capital | Reiterated | Outperform | 2026-08-19 | $318.00 | +25.80% |
Wells Fargo | Reiterated | Equal Weight | 2026-08-14 | $256.00 | +1.30% |
Truist Securities | Reiterated | Buy | 2026-08-04 | — | — |
Raymond James | Upgraded | Outperform → Strong Buy | 2026-08-03 | $420.00 | +66.20% |
Barclays | Reiterated | Overweight | 2026-08-03 | $450.00 | +78.00% |
Citigroup | Reiterated | Buy | 2026-08-03 | $211.00 | −16.50% |
Stifel | Reiterated | Buy | 2026-07-31 | — | — |
JP Morgan | Reiterated | Overweight | 2026-07-31 | — | — |
RBC Capital | Reiterated | Outperform | 2026-07-31 | $350.00 | +38.50% |
Morgan Stanley | Reiterated | Equal Weight | 2026-07-31 | $300.00 | +18.70% |
Oppenheimer | Reiterated | Outperform | 2026-07-31 | $350.00 | +38.50% |
Chardan Capital | Reiterated | Buy | 2026-07-31 | $425.00 | +68.10% |
Needham | Reiterated | Buy | 2026-07-30 | $529.00 | +109.30% |
B of A Securities | Reiterated | Buy | 2026-07-14 | — | — |
Freedom Capital Markets | Upgraded | Hold → Buy | 2026-02-17 | — | — |
Freedom Broker | Upgraded | Hold → Buy | 2026-02-17 | — | — |
Canaccord Genuity | Reiterated | Buy | 2026-02-17 | $429.00 | +69.70% |
Leerink Partners | Reiterated | Market Perform | 2025-12-15 | $351.00 | +38.90% |
Piper Sandler | Reiterated | Overweight | 2025-10-31 | $253.00 | +0.10% |
Goldman Sachs | Reiterated | Buy | 2025-09-16 | $370.00 | +46.40% |
Evercore ISI Group | Reiterated | Outperform | 2025-09-11 | — | — |
Wolfe Research | Upgraded | Underperform → Peer Perform | 2025-08-04 | — | — |
Scotiabank | Reiterated | Sector Outperform | 2025-08-01 | $338.00 | +33.70% |
UBS | Reiterated | Buy | 2025-08-01 | $549.00 | +117.20% |
Bernstein | Reiterated | Outperform | 2025-01-07 | $376.00 | +48.80% |
TD Cowen | Reiterated | Buy | 2024-10-21 | — | — |
Cantor Fitzgerald | Reiterated | Neutral | 2024-10-11 | $450.00 | +78.00% |
SMBC Nikko | Reiterated | Neutral | 2023-04-26 | — | — |
SVB Leerink | Reiterated | Market Perform | 2023-01-23 | — | — |
Guggenheim | Downgraded | Buy → Neutral | 2022-06-27 | $170.00 | −32.70% |
William Blair | Reiterated | Outperform | 2022-06-07 | — | — |
Nomura | Reiterated | Reduce | 2020-04-14 | — | — |
Berenberg | Reiterated | Buy | 2020-03-19 | — | — |
Bank of America | Reiterated | Buy | 2019-11-13 | — | — |
Piper Jaffray | Reiterated | Overweight | 2019-09-03 | — | — |
Stifel Nicolaus | Reiterated | Buy | 2019-04-15 | $318.00 | +25.80% |
Leerink Swann | Reiterated | Market Perform → Perform | 2018-11-28 | — | — |
B. Riley FBR | Reiterated | Buy | 2018-08-13 | — | — |
B. Riley Securities | Reiterated | Buy | 2018-08-13 | — | — |
Cowen & Co. | Reiterated | Outperform | 2018-08-13 | $250.00 | −1.10% |
Credit Suisse | Reiterated | Outperform | 2018-03-13 | — | — |
B. Riley | Reiterated | Buy | 2017-11-08 | — | — |
FBR Capital | Reiterated | Buy | 2017-11-02 | — | — |
Ladenburg Thalmann | Reiterated | Buy | 2017-02-02 | — | — |
Janney Capital | Reiterated | Neutral | 2016-09-29 | — | — |
JMP Securities | Reiterated | Market Outperform | 2016-03-09 | — | — |
PiperJaffray | Reiterated | Outperform | 2015-06-15 | — | — |
S&P Capital IQ | Upgraded | Hold → Buy | 2014-01-27 | — | — |
Deutsche Bank | Reiterated | Buy | 2013-09-24 | — | — |
McNicoll Lewis Vlak | Downgraded | Buy → Hold | 2013-02-09 | — | — |
Institution
HC Wainwright & Co.
Reiterated · Buy · 2026-09-21
—
—
Jefferies
Reiterated · Hold · 2026-09-08
$260.00
+2.90%
BMO Capital
Reiterated · Outperform · 2026-08-19
$318.00
+25.80%
Wells Fargo
Reiterated · Equal Weight · 2026-08-14
$256.00
+1.30%
Truist Securities
Reiterated · Buy · 2026-08-04
—
—
Raymond James
Upgraded · Outperform → Strong Buy · 2026-08-03
$420.00
+66.20%
Barclays
Reiterated · Overweight · 2026-08-03
$450.00
+78.00%
Citigroup
Reiterated · Buy · 2026-08-03
$211.00
−16.50%
Stifel
Reiterated · Buy · 2026-07-31
—
—
JP Morgan
Reiterated · Overweight · 2026-07-31
—
—
RBC Capital
Reiterated · Outperform · 2026-07-31
$350.00
+38.50%
Morgan Stanley
Reiterated · Equal Weight · 2026-07-31
$300.00
+18.70%
Oppenheimer
Reiterated · Outperform · 2026-07-31
$350.00
+38.50%
Chardan Capital
Reiterated · Buy · 2026-07-31
$425.00
+68.10%
Needham
Reiterated · Buy · 2026-07-30
$529.00
+109.30%
B of A Securities
Reiterated · Buy · 2026-07-14
—
—
Freedom Capital Markets
Upgraded · Hold → Buy · 2026-02-17
—
—
Freedom Broker
Upgraded · Hold → Buy · 2026-02-17
—
—
Canaccord Genuity
Reiterated · Buy · 2026-02-17
$429.00
+69.70%
Leerink Partners
Reiterated · Market Perform · 2025-12-15
$351.00
+38.90%
Piper Sandler
Reiterated · Overweight · 2025-10-31
$253.00
+0.10%
Goldman Sachs
Reiterated · Buy · 2025-09-16
$370.00
+46.40%
Evercore ISI Group
Reiterated · Outperform · 2025-09-11
—
—
Wolfe Research
Upgraded · Underperform → Peer Perform · 2025-08-04
—
—
Scotiabank
Reiterated · Sector Outperform · 2025-08-01
$338.00
+33.70%
UBS
Reiterated · Buy · 2025-08-01
$549.00
+117.20%
Bernstein
Reiterated · Outperform · 2025-01-07
$376.00
+48.80%
TD Cowen
Reiterated · Buy · 2024-10-21
—
—
Cantor Fitzgerald
Reiterated · Neutral · 2024-10-11
$450.00
+78.00%
SMBC Nikko
Reiterated · Neutral · 2023-04-26
—
—
SVB Leerink
Reiterated · Market Perform · 2023-01-23
—
—
Guggenheim
Downgraded · Buy → Neutral · 2022-06-27
$170.00
−32.70%
William Blair
Reiterated · Outperform · 2022-06-07
—
—
Nomura
Reiterated · Reduce · 2020-04-14
—
—
Berenberg
Reiterated · Buy · 2020-03-19
—
—
Bank of America
Reiterated · Buy · 2019-11-13
—
—
Piper Jaffray
Reiterated · Overweight · 2019-09-03
—
—
Stifel Nicolaus
Reiterated · Buy · 2019-04-15
$318.00
+25.80%
Leerink Swann
Reiterated · Market Perform → Perform · 2018-11-28
—
—
B. Riley FBR
Reiterated · Buy · 2018-08-13
—
—
B. Riley Securities
Reiterated · Buy · 2018-08-13
—
—
Cowen & Co.
Reiterated · Outperform · 2018-08-13
$250.00
−1.10%
Credit Suisse
Reiterated · Outperform · 2018-03-13
—
—
B. Riley
Reiterated · Buy · 2017-11-08
—
—
FBR Capital
Reiterated · Buy · 2017-11-02
—
—
Ladenburg Thalmann
Reiterated · Buy · 2017-02-02
—
—
Janney Capital
Reiterated · Neutral · 2016-09-29
—
—
JMP Securities
Reiterated · Market Outperform · 2016-03-09
—
—
PiperJaffray
Reiterated · Outperform · 2015-06-15
—
—
S&P Capital IQ
Upgraded · Hold → Buy · 2014-01-27
—
—
Deutsche Bank
Reiterated · Buy · 2013-09-24
—
—
McNicoll Lewis Vlak
Downgraded · Buy → Hold · 2013-02-09
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space